An invited session on novel endpoints in clincial trials was held at the Australian Trials Methodology Conference (external link, opens in a new window) where Prof Jaki spoke on using more informative outcomes during early phase clinical trials. His presentation focused on dose-escalation trials for combination treatments in oncology that use long term outcomes of safety and activity.